Filing Details

Accession Number:
0001140361-11-022445
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-18 17:09:39
Reporting Period:
2011-04-15
Filing Date:
2011-04-18
Accepted Time:
2011-04-18 17:09:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1033905 Luminex Corp LMNX Surgical & Medical Instruments & Apparatus (3841) 742747608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238407 T Harriss Currie 12212 Technology Boulevard
Austin TX 78727
Vp Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-04-15 4,000 $13.05 96,329 No 4 M Direct
Common Stock Disposition 2011-04-15 4,000 $19.08 92,329 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2011-04-15 4,000 $0.00 4,000 $13.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-04-25 2011-04-25 No 4 M Direct
Footnotes
  1. This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 adopted by the seller on February 14, 2011. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.04 to $19.23 inclusive. Mr. Currie undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.